Tonix Pharmaceuticals Holding (TNXP) : Traders are bullish on Tonix Pharmaceuticals Holding (TNXP) as it has outperformed the S&P 500 by a wide margin of 24.21% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 23.61%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 23.67% in the last 1 week, and is up 25.49% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The stock has recorded a 20-day Moving Average of 23.52% and the 50-Day Moving Average is 18.02%. Tonix Pharmaceuticals Holding (NASDAQ:TNXP): stock turned positive on Friday. Though the stock opened at $2.23, the bulls momentum made the stock top out at $2.5799 level for the day. The stock recorded a low of $2.2 and closed the trading day at $2.56, in the green by 13.78%. The total traded volume for the day was 932,178. The stock had closed at $2.25 in the previous days trading.
The company Insiders own 10.2% of Tonix Pharmaceuticals Holding shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by 22.86% . Institutional Investors own 30.76% of Tonix Pharmaceuticals Holding shares. During last six month period, the net percent change held by insiders has seen a change of 49.62%. Also, Equity Analysts at the Brokerage Firm, Cantor Fitzgerald, upgrades their rating on the shares of Tonix Pharmaceuticals Holding (NASDAQ:TNXP). Cantor Fitzgerald has a Buy rating on the shares. Previously, the analysts had a Speculative Buy rating on the shares. The rating by the firm was issued on June 2, 2016.